HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glycyl- leucyl- cysteinyl- threonyl- leucyl- valyl- alanyl- methionyl- leucine

an early lytic peptide

Also Known As:

BMLF1 peptide; GLCTLVAML

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - glycyl-leucyl-cysteinyl-threonyl-leucyl-valyl-alanyl-methionyl-leucine: 3

Experts

1.	Georgoulias, Panagiotis: 1 article (06/2010)
2.	Germenis, Anastasios E: 1 article (06/2010)
3.	Gourgoulianis, Konstantinos I: 1 article (06/2010)
4.	Karanikas, Vaios: 1 article (06/2010)
5.	Kerenidi, Theodora: 1 article (06/2010)
6.	Soukou, Faye: 1 article (06/2010)
7.	Theodorou, Kiki: 1 article (06/2010)
8.	Tsougos, Ioannis: 1 article (06/2010)
9.	Zamanakou, Maria: 1 article (06/2010)
10.	Abbott, Rachel J M: 1 article (09/2009)

Related Diseases

1.	Epstein-Barr Virus Infections 09/01/2009 - "However, we noticed that in HLA-A 0201-positive infectious mononucleosis (IM) patients undergoing primary Epstein-Barr virus (EBV) infection, the initial CD8 response targets three EBV lytic antigen-derived epitopes, YVLDHLIVV (YVL), GLCTLVAML (GLC), and TLDYKPLSV (TLD), but only the YVL and GLC reactivities persist long-term; the TLD response disappears within 10 to 27 months. "
2.	Lung Neoplasms (Lung Cancer) 06/04/2010 - "Peripheral blood mononuclear cells from lung cancer patients, age-matched and younger healthy individuals were used to measure EBV-specific CTLs after in vitro amplification with the GLCTLVAML and RYSIFFDYM peptides followed by HLA-multimer staining. "
3.	Human Influenza (Influenza) 01/01/2000 - "This enrichment does not reflect a generalized enrichment for the 'memory pool' of T cells; we did not find enrichment of T cells specific for the GILGFVFTL epitope from influenza A or for the FLRGRAYGL epitope from the EBV latent protein EBNA3A, whereas we found clear enrichment of T cells specific for the GLCTLVAML epitope from the EBV lytic protein BMLF1 and for the RAKFKQLL epitope from the EBV lytic protein BZLF1. " 01/01/2000 - "Samples from human leucocyte antigen (HLA)-A2-positive donors were stained with fluorescent-labelled tetramers of HLA-A2 complexed with the GLCTLVAML peptide epitope from the EBV lytic cycle protein BMLF1, the GILGFVFTL peptide epitope from the influenza A matrix protein, or the NLVPMVATV epitope from the CMV pp65 protein. "
4.	Infectious Mononucleosis (Glandular Fever) 09/01/2009 - "However, we noticed that in HLA-A 0201-positive infectious mononucleosis (IM) patients undergoing primary Epstein-Barr virus (EBV) infection, the initial CD8 response targets three EBV lytic antigen-derived epitopes, YVLDHLIVV (YVL), GLCTLVAML (GLC), and TLDYKPLSV (TLD), but only the YVL and GLC reactivities persist long-term; the TLD response disappears within 10 to 27 months. "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Antigens
3.	Epitopes
4.	HLA-A2 Antigen (HLA A2 Antigen)
5.	HLA-A Antigens (HLA-A)
6.	Proteins (Proteins, Gene)
7.	influenza matrix peptide (58-66)